Renoprotective effects of angiotensin II receptor blocker, candesartan cilexetil, in patients with stage 4–5 chronic kidney disease

被引：0
|
作者：
Yoshifuru Tamura
Masahiro Kosuga
Masahiro Yamashita
Satoru Tomioka
Michiko Sasaki
Tomoyuki Hikita
Hideaki Nakajima
Kenichiro Kojima
Shunya Uchida
机构：
[1] Teikyo University School of Medicine,Division of Nephrology, Department of Internal Medicine
来源：
Clinical and Experimental Nephrology | 2008年 / 12卷
关键词：
Angiotensin II receptor blocker; Candesartan cilexetil; Chronic kidney disease; Hypertension; Renoprotective effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：256 / 263
页数：7
相关论文
共 50 条
  • [21] Angiotensin receptor antagonism with candesartan decreases arterial stiffness in patients with chronic kidney disease
    Rushentsova, Uliana
    Zinoviev, Alex
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 70 - 70
  • [22] Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension
    Skurk, T
    Lee, YM
    Nicuta-Rölfs, TO
    Haastert, B
    Wirth, A
    Hauner, H
    DIABETES OBESITY & METABOLISM, 2004, 6 (01): : 56 - 62
  • [23] Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure
    Yoshimura, M
    Yasue, H
    CARDIOLOGY, 2000, 93 (03) : 175 - 182
  • [24] Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis
    Chou, C. -Y.
    Wang, S. -M.
    Chang, P. -H.
    Kuo, H. -L.
    Chang, C. -T.
    Liu, J. -H.
    Wang, I. -K.
    Yang, Y. -F.
    Liang, C. -C.
    Huang, C. -C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (07) : 722 - 728
  • [25] Effects of angiotensin II receptor blocker (candesartan) in daunorubicin-induced cardiomyopathic rats
    Soga, Mayako
    Kamal, Fadia A.
    Watanabe, Kenichi
    Ma, Meilei
    Palaniyandi, Suresh
    Prakash, Paras
    Veeraveedu, Punniyakoti
    Mito, Sayaka
    Kunisaki, Megumi
    Tachikawa, Hitoshi
    Kodama, Makoto
    Aizawa, Yoshifusa
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (03) : 378 - 385
  • [26] ACE Inhibitor and angiotensin receptor blocker use and mortality in patients with chronic kidney disease
    South China Journal of Cardiology, 2013, (04) : 291 - 291
  • [27] Effects of the angiotensin II type 1 receptor blocker candesartan on cardiovascular events in high-risk patients
    Kondo, J
    Sone, T
    Tsuboi, H
    Mukawa, H
    Kosokabe, T
    Uesugi, F
    Morishima, I
    EUROPEAN HEART JOURNAL, 2001, 22 : 716 - 716
  • [28] Candesartan cilexetil/lisinoprilLate onset uraemia with increasing creatinine levels in patients with chronic kidney disease: 5 case reports
    Reactions Weekly, 2008, 1192 (1) : 13 - 13
  • [29] Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
    Kim, Eun Seok
    Kim, Hyun Jeong
    Kim, Yong Jun
    Lee, Su Mi
    Lee, Ho Jin
    Cho, Duk Song
    Son, Young Ki
    Kim, Seong Eun
    Kim, Ki Hyun
    An, Won Suk
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2013, 32 (04) : 158 - 163
  • [30] Angiotensin II Receptor Blocker Candesartan Cilexetil, but Not Hydralazine Hydrochloride, Protects Against Mouse Cardiac Enlargement Resulting From Undernutrition In Utero
    Makoto Kawamura
    Hiroaki Itoh
    Shigeo Yura
    Haruta Mogami
    Tsuyoshi Fujii
    Naohiro Kanayama
    Ikuo Konishi
    Reproductive Sciences, 2009, 16 : 1005 - 1012
12345